Page last updated: 2024-10-28

n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide and Torsade de Pointes

n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide has been researched along with Torsade de Pointes in 2 studies

Research Excerpts

ExcerptRelevanceReference
"The ventricular arrhythmia torsade de pointes (TdP) occurs after QT interval prolongation and is associated with sudden cardiac death."1.30Systemic administration of calmodulin antagonist W-7 or protein kinase A inhibitor H-8 prevents torsade de pointes in rabbits. ( Anderson, ME; Mazur, A; Roden, DM, 1999)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kijtawornrat, A1
Ziolo, MT1
Nishijima, Y1
Roche, BM1
Hamlin, RL1
Mazur, A1
Roden, DM1
Anderson, ME1

Other Studies

2 other studies available for n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide and Torsade de Pointes

ArticleYear
Effects of sarcolemmal Ca(2+) entry, ryanodine function, and kinase inhibitors on a rabbit model of heart failure.
    International heart journal, 2010, Volume: 51, Issue:4

    Topics: Animals; Anti-Arrhythmia Agents; Benzylamines; Disease Models, Animal; Heart Failure; Isoquinolines;

2010
Systemic administration of calmodulin antagonist W-7 or protein kinase A inhibitor H-8 prevents torsade de pointes in rabbits.
    Circulation, 1999, Dec-14, Volume: 100, Issue:24

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e

1999